IMCR logo

Immunocore Holdings (IMCR) Cash and cash equivalents

annual cash & cash equivalents:

$455.73M+$13.11M(+2.96%)
December 31, 2024

Summary

  • As of today (June 27, 2025), IMCR annual cash & cash equivalents is $455.73 million, with the most recent change of +$13.11 million (+2.96%) on December 31, 2024.
  • During the last 3 years, IMCR annual cash & cash equivalents has risen by +$134.67 million (+41.95%).
  • IMCR annual cash & cash equivalents is now at all-time high.

Performance

IMCR Cash and cash equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIMCRbalance sheet metrics

quarterly cash & cash equivalents:

$476.85M+$21.11M(+4.63%)
March 31, 2025

Summary

  • As of today (June 27, 2025), IMCR quarterly cash & cash equivalents is $476.85 million, with the most recent change of +$21.11 million (+4.63%) on March 31, 2025.
  • Over the past year, IMCR quarterly cash & cash equivalents has dropped by -$355.98 million (-42.74%).
  • IMCR quarterly cash & cash equivalents is now -42.74% below its all-time high of $832.82 million, reached on March 31, 2024.

Performance

IMCR quarterly cash & cash equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIMCRbalance sheet metrics

Cash and cash equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

IMCR Cash and cash equivalents Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+3.0%-42.7%
3 y3 years+42.0%+76.3%
5 y5 years+369.9%-

IMCR Cash and cash equivalents Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+42.0%-42.7%+89.0%
5 y5-yearat high+369.9%-42.7%+553.9%
alltimeall timeat high+369.9%-42.7%+553.9%

IMCR Cash and cash equivalents History

DateAnnualQuarterly
Mar 2025
-
$476.85M(+4.6%)
Dec 2024
$455.73M(+3.0%)
$455.73M(-15.3%)
Sep 2024
-
$537.77M(+6.5%)
Jun 2024
-
$504.99M(-39.4%)
Mar 2024
-
$832.82M(+88.2%)
Dec 2023
$442.63M(+10.0%)
$442.63M(-0.3%)
Sep 2023
-
$444.06M(+2.8%)
Jun 2023
-
$431.80M(+3.3%)
Mar 2023
-
$417.95M(+3.8%)
Dec 2022
$402.47M
$402.47M(+3.8%)
DateAnnualQuarterly
Sep 2022
-
$387.70M(+53.6%)
Jun 2022
-
$252.36M(-6.7%)
Mar 2022
-
$270.41M(-15.8%)
Dec 2021
$321.06M(+81.6%)
$321.06M(-6.8%)
Sep 2021
-
$344.47M(-10.7%)
Jun 2021
-
$385.96M(-10.3%)
Mar 2021
-
$430.34M(+143.4%)
Dec 2020
$176.78M(+82.3%)
$176.78M(+142.4%)
Sep 2020
-
$72.92M(-24.8%)
Dec 2019
$96.98M(-38.6%)
$96.98M
Dec 2018
$157.83M
-

FAQ

  • What is Immunocore Holdings annual cash & cash equivalents?
  • What is the all time high annual cash & cash equivalents for Immunocore Holdings?
  • What is Immunocore Holdings annual cash & cash equivalents year-on-year change?
  • What is Immunocore Holdings quarterly cash & cash equivalents?
  • What is the all time high quarterly cash & cash equivalents for Immunocore Holdings?
  • What is Immunocore Holdings quarterly cash & cash equivalents year-on-year change?

What is Immunocore Holdings annual cash & cash equivalents?

The current annual cash & cash equivalents of IMCR is $455.73M

What is the all time high annual cash & cash equivalents for Immunocore Holdings?

Immunocore Holdings all-time high annual cash & cash equivalents is $455.73M

What is Immunocore Holdings annual cash & cash equivalents year-on-year change?

Over the past year, IMCR annual cash & cash equivalents has changed by +$13.11M (+2.96%)

What is Immunocore Holdings quarterly cash & cash equivalents?

The current quarterly cash & cash equivalents of IMCR is $476.85M

What is the all time high quarterly cash & cash equivalents for Immunocore Holdings?

Immunocore Holdings all-time high quarterly cash & cash equivalents is $832.82M

What is Immunocore Holdings quarterly cash & cash equivalents year-on-year change?

Over the past year, IMCR quarterly cash & cash equivalents has changed by -$355.98M (-42.74%)
On this page